These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12199759)

  • 41. Analysis of clinicopathologic factors in malignant mixed Müllerian tumors of the uterine corpus.
    Inthasorn P; Carter J; Valmadre S; Beale P; Russell P; Dalrymple C
    Int J Gynecol Cancer; 2002; 12(4):348-53. PubMed ID: 12144682
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mullerian adenosarcoma (heterologous) of uterine cervix with sarcomatous overgrowth: A case report with review of the literature.
    Mohapatra D; Mohanty P; Biswal R
    Indian J Pathol Microbiol; 2019; 62(1):139-141. PubMed ID: 30706880
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Primitive neuroectodermal tumor of the uterus--a monophasic differentiated mixed Mullerian tumor?].
    Christensen B; Schmidt U; Schindler A
    Zentralbl Gynakol; 1994; 116(10):577-80. PubMed ID: 7810246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ANNA-1 (anti-Hu) associated sensory neuronopathy with malignant mixed mullerian tumor.
    Fournier CN; Kalra A; Lachance DH; Zarwan C; Srinivasan J
    Muscle Nerve; 2013 May; 47(5):776-7. PubMed ID: 23536385
    [No Abstract]   [Full Text] [Related]  

  • 45. Cervicovaginal (Papanicolaou) smear findings in patients with malignant mixed Müllerian tumors.
    Casey MB; Caudill JL; Salomão DR
    Diagn Cytopathol; 2003 May; 28(5):245-9. PubMed ID: 12722119
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synchronous presentation of breast carcinoma and lymphoma in the axillary nodes.
    Cox J; Lunt L; Webb L
    Breast; 2006 Apr; 15(2):246-52. PubMed ID: 16188443
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carcinosarcomas (malignant mixed Müllerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics.
    Kernochan LE; Garcia RL
    J Natl Compr Canc Netw; 2009 May; 7(5):550-6; quiz 557. PubMed ID: 19460280
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Malignant mixed mullerian tumours of the body of the uterus: a clinicopathological study of 20 cases.
    Muthuphei MN; Maluleke HJ
    Cent Afr J Med; 1998 Feb; 44(2):45-7. PubMed ID: 9675973
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metastasis of primitive neuroectodermal tumor to the breast.
    Kwak JY; Kim EK; You JK; Oh KK; Hong SW; Kim SH
    J Clin Ultrasound; 2002; 30(6):374-7. PubMed ID: 12116099
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Malignant mixed muellerian tumour of uterus.
    Sinha SK; Basu N; Biswas PK; Sanyal S; De KC
    J Indian Med Assoc; 1995 Sep; 93(9):363. PubMed ID: 8648164
    [No Abstract]   [Full Text] [Related]  

  • 51. Dynamic enhanced computed tomography values of locally advanced breast cancers predicting axilla nodal metastasis after neoadjuvant chemotherapy.
    Cheung YC; Chen SC; Ueng SH; Ko SF; Wan YL
    J Comput Assist Tomogr; 2009; 33(3):422-5. PubMed ID: 19478638
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Uterine malignant mixed Müllerian tumor (Metaplasic carcinoma) in the cat: clinicopathologic features and proliferation indices.
    Nicòtina PA; Zanghì A; Catone G
    Vet Pathol; 2002 Jan; 39(1):158-60. PubMed ID: 12102212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carcinosarcoma, endometrial intraepithelial carcinoma and endometriosis after tamoxifen therapy in breast cancer.
    Friedrich M; Villena-Heinsen C; Mink D; Bonkhoff H; Schmidt W
    Eur J Obstet Gynecol Reprod Biol; 1999 Jan; 82(1):85-7. PubMed ID: 10192492
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Imaging findings of variable axillary mass and axillary lymphadenopathy.
    Park SH; Jeong YM; Cho SH; Jung HK; Kim SJ; Ryu HS
    Ultrasound Med Biol; 2014 Sep; 40(9):1934-48. PubMed ID: 24948395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Carcinosarcoma of the endometrium with melanocytic differentiation, case report].
    Berezovskiy D; Vlasák P; Kosťun J; Bouda J; Presl J
    Ceska Gynekol; 2017; 82(5):390-395. PubMed ID: 29020787
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Malignant mixed mullerian tumor of the uterus in a patient taking raloxifene.
    Goldman NA; de Los Angeles MM; Jones JG; Goldberg GL
    Obstet Gynecol; 2005 May; 105(5 Pt 2):1278-80. PubMed ID: 15863610
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Malignant mixed Mullerian tumor of the uterine corpus with alpha-fetoprotein-producing hepatoid adenocarcinoma component.
    Takano M; Shibasaki T; Sato K; Aida S; Kikuchi Y
    Gynecol Oncol; 2003 Nov; 91(2):444-8. PubMed ID: 14599882
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Uterine inversion by a mixed müllerian tumor of the corpus.
    Tjalma WA; Naik R; Monaghan JM; De Barros Lopes A
    Int J Gynecol Cancer; 2003; 13(6):894-7. PubMed ID: 14675330
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Malignant müllerian mixed tumor of the uterus with a prominent alpha-fetoprotein-producing component of yolk sac tumor.
    Shokeir MO; Noel SM; Clement PB
    Mod Pathol; 1996 Jun; 9(6):647-51. PubMed ID: 8782202
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Positron emission tomography-computed tomography in the detection of axillary lymph node metastasis in patients with early stage breast cancer.
    Chae BJ; Bae JS; Kang BJ; Kim SH; Jung SS; Song BJ
    Jpn J Clin Oncol; 2009 May; 39(5):284-9. PubMed ID: 19318373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.